Oct 30, 2025 / 10:00AM GMT
Presentation
Oct 30, 2025 / 10:00AM GMT
=====================
Corporate Participants
=====================
* Christopher O'Reilly
Takeda Pharmaceutical Co Ltd - Global Head of Investor Relations
* Christophe Weber
Takeda Pharmaceutical Co Ltd - President, Chief Executive Officer, Representative Director
* Milano Furuta
Takeda Pharmaceutical Co Ltd - Chief Financial Officer, Director
* Andrew Plump
Takeda Pharmaceutical Co Ltd - President of Research & Development, Vice President of Subsidiary, Director
* Teresa Bitetti
Takeda Pharmaceutical Co Ltd - President, Global Oncology, Takeda
* Phuong Morrow
Takeda Pharmaceutical Co Ltd - Head, Oncology Therapeutic Area Unit
* Julie Kim
Takeda Pharmaceutical Co Ltd - President of the US Business Unit, US Country Head & Interim Head of Global Portfolio Division
* Giles Platford
Takeda Pharmaceutical Co Ltd - President, Plasma-Derived Therapies Business
=====================
Conference Call Participants
============
Takeda Pharmaceutical Co Ltd
(NYSE:TAK)
$
15.91
+0.26 (+1.66%)
Market Cap: 50.27 Bil
Enterprise Value: 76.83 Bil
PE Ratio: 0
PB Ratio: 1.08
GF Score: 76/100 Q2 2026 Takeda Pharmaceutical Co Ltd Earnings Presentation Transcript
Oct 30, 2025 / 10:00AM GMT
Release Date Price:
$13.23
(-3.92%)
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot